{"id":15961,"date":"2018-09-10T09:36:55","date_gmt":"2018-09-10T09:36:55","guid":{"rendered":"https:\/\/celonpharma.com\/?p=15961"},"modified":"2018-09-10T09:36:55","modified_gmt":"2018-09-10T09:36:55","slug":"celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/","title":{"rendered":"Celon Pharma enhances its platform for the development of biotechnology drugs"},"content":{"rendered":"<p><span lang=\"EN-GB\">The company has established substantive cooperation with Pure Biologics S.A., a biopharmaceutical company. The two entities will cooperate in the field of research and development on biotechnological drugs, which will result in the identification of potential biotech drug candidates, which Celon Pharma will subsequently be developing in preclinical and clinical areas.<\/span><\/p>\n<p><strong><span lang=\"EN-GB\" style=\"color: #8a8a8a;\">Maciej Wieczorek, PhD, CEO of Celon Pharma S.A.:\u00a0<\/span><\/strong><em><span lang=\"EN-GB\" style=\"color: #8a8a8a;\">We are consistently expanding our portfolio of innovative drugs, in which biotechnology drugs will play an increasingly important role. Our areas of interest are various classes of modified antibodies characterised by therapeutic potential in inflammatory diseases and other rare autoimmune diseases. We have also enhanced our team of researchers at our R&amp;D Centre by welcoming new experts specialising in the development of biotech projects. We are convinced our cooperation with Pure Biologics will be smooth and fruitful.<\/span><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The company has established substantive cooperation with Pure Biologics S.A., a biopharmaceutical company. The two entities will cooperate in the field of research and development on biotechnological drugs, which will result in the identification of potential biotech drug candidates, which Celon Pharma will subsequently be developing in preclinical and clinical areas. Maciej Wieczorek, PhD, CEO<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/\" title=\"ReadCelon Pharma enhances its platform for the development of biotechnology drugs\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-15961","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Celon Pharma enhances its platform for the development of biotechnology drugs - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma enhances its platform for the development of biotechnology drugs - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"The company has established substantive cooperation with Pure Biologics S.A., a biopharmaceutical company. The two entities will cooperate in the field of research and development on biotechnological drugs, which will result in the identification of potential biotech drug candidates, which Celon Pharma will subsequently be developing in preclinical and clinical areas. Maciej Wieczorek, PhD, CEORead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-10T09:36:55+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/\",\"url\":\"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/\",\"name\":\"Celon Pharma enhances its platform for the development of biotechnology drugs - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2018-09-10T09:36:55+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma enhances its platform for the development of biotechnology drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma enhances its platform for the development of biotechnology drugs - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma enhances its platform for the development of biotechnology drugs - CelonGROUP","og_description":"The company has established substantive cooperation with Pure Biologics S.A., a biopharmaceutical company. The two entities will cooperate in the field of research and development on biotechnological drugs, which will result in the identification of potential biotech drug candidates, which Celon Pharma will subsequently be developing in preclinical and clinical areas. Maciej Wieczorek, PhD, CEORead more &raquo;","og_url":"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/","og_site_name":"CelonGROUP","article_published_time":"2018-09-10T09:36:55+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/","url":"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/","name":"Celon Pharma enhances its platform for the development of biotechnology drugs - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2018-09-10T09:36:55+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2018\/09\/10\/celon-pharma-enhances-its-platform-for-the-development-of-biotechnology-drugs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma enhances its platform for the development of biotechnology drugs"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=15961"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/15961\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=15961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=15961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=15961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}